
Intuitive Surgical Achieves 23% Revenue Surge to $2.51B in Q3 2025
Intuitive Surgical, Inc.Description
What this story covers
Intuitive Surgical's Q3 2025 10-Q shows 23% revenue growth to $2.51B, driven by 19% rise in da Vinci procedures to 797K and Ion biopsies up 52%. Installed base exceeds 10K systems; recurring revenue at 85%. Strong cash supports innovation like da Vinci 5 amid risks.
Story snapshot
CompanyIntuitive Surgical, Inc.
TickerISRG
VariantStandard detailed
Duration13:28
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001035267-25-000209
Full Story Script
Content not available for this story.